Clinical Trials Browser

Recruiting × palbociclib × Sarcoma × Clear all

NCT06113809 2026-05-22

Palbociclib and Pembrolizumab in Sarcoma

Phase 1 Recruiting

Sarcoma

NCT06843967 2026-05-22

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Phase 1/2 Recruiting

Liposarcoma, Liposarcoma, Myxoid